Review of current treatment options for pregnancy-associated breast cancer

Clinical Obstetrics and Gynecology

Volumn 54, Issue 1, 2011, Pages 164-172

  Sukumvanich, Paniti ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Breast carcinoma; PABC; Pregnancy; Pregnancy associated breast cancer; Treatment

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; INDIGO CARMINE; ISOSULFAN BLUE; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TECHNETIUM SULFUR COLLOID TC 99M; TRASTUZUMAB;

AMBIGUOUS GENITALIA; ANHYDRAMNIOS; BONE SCINTISCANNING; BREAST CANCER; BREAST FEEDING; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CLUBFOOT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIGITAL MAMMOGRAPHY; DISEASE FREE SURVIVAL; DOWN SYNDROME; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; GOLDENHAR SYNDROME; HUMAN; MAMMOGRAPHY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOHYDRAMNIOS; PARTIAL MASTECTOMY; PREGNANCY ASSOCIATED BREAST CANCER; PROGNOSIS; RADIATION EXPOSURE; RADIODIAGNOSIS; REVIEW; RISK; SPONTANEOUS ABORTION; SUBARACHNOID HEMORRHAGE; TERATOGENESIS; THORAX RADIOGRAPHY;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS;

EID: 79951666869     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182083a44     Document Type: Review

References (21)

1. Berlin L. Radiation exposure and the pregnant patient. AJR Am J Roentgenol. 1996;167:1377-1379. (Pubitemid 26418716)
2. Kok RD, de Vries MM, Heerschap A, et al. Absence of harmful effects of magnetic resonance exposure at 1.5 T in utero during the third trimester of pregnancy: a follow-up study. Magn Reson Imaging. 2004;22:851-854. (Pubitemid 38962322)
3. Ginsberg JS, Hirsh J, Rainbow AJ, et al. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost. 1989;61:189-196. (Pubitemid 19124387)
4. Clements H, Duncan KR, Fielding K, et al. Infants exposed to MRI in utero have a normal paediatric assessment at 9 months of age. Br J Radiol. 2000;73: 190-194. (Pubitemid 30179228)
5. Mevissen M, Buntenkotter S, Loscher W. Effects of static and time-varying (50-Hz) magnetic fields on reproduction and fetal development in rats. Teratology. 1994; 50:229-237. (Pubitemid 24343546)
6. Shen T, Vortmeyer AO, Zhuang Z, et al. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma. J Natl Cancer Inst. 1999;91: 1686-1687. (Pubitemid 29479939)
7. Johannsson O, Loman N, Borg A, et al. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 1998;352:1359-1360. (Pubitemid 28510925)
8. Elledge RM, Ciocca DR, Langone G, et al. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer. 1993;71:2499-2506. (Pubitemid 23100483)
9. Middleton LP, Amin M, Gwyn K, et al. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer. 2003;98:1055-1060. (Pubitemid 37022108)
10. Reed W, Sandstad B, Holm R, et al. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int J Surg Pathol. 2003;11:65-74. (Pubitemid 36569927)
11. Shousha S. Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med. 2000; 124:1053-1060. (Pubitemid 30602049)
12. Holleb AI, Farrow JH. The relation of carcinoma of the breast and pregnancy in 283 patients. Surgery, Gynecology Obstetrics. 1962;115:65-71.
13. Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006;106: 237-246. (Pubitemid 43100430)
14. Elkhuizen PH, van Slooten HJ, Clahsen PC, et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol. 2000;18: 1075-1083. (Pubitemid 30123786)
15. Keleher A, Wendt R III, Delpassand E, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10: 492-495. (Pubitemid 39524981)
16. Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol. 2007;14:218-221. (Pubitemid 44954292)
17. Uhara H, Takata M, Saida T. Sentinel lymph node biopsy in Japan. Int J Clin Oncol. 2009;14:490-496.
18. HahnKM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107:1219-1226. (Pubitemid 44452769)
19. Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005;23:4192-4197. (Pubitemid 46211325)
20. Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer. 1991;67:869-872.
21. Rodriguez AO, Chew H, Cress R, et al. Evidence of poorer survival in pregnancyassociated breast cancer. Obstet Gynecol. 2008;112:71-78.